These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4125580)

  • 21. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.
    Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA
    Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A histochemical study of glycosidases in benign prostatic hyperplasia and in prostatic carcinoma in the human.
    Sinowatz F; Weber P; Gasser G; Mossig H; Skolek-Winnisch R
    Urol Res; 1978; 6(2):103-7. PubMed ID: 78561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some biochemical and histochemical aspects in hyperplasia and carcinoma of the human prostate.
    Nilsson T; Müntzing J
    J Surg Oncol; 1973; 5(3):205-14. PubMed ID: 4712286
    [No Abstract]   [Full Text] [Related]  

  • 24. Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia.
    Pretlow TG; Whitehurst GB; Pretlow TP; Hunt RS; Jacobs JM; McKenzie DR; McDaniel HG; Hall LM; Bradley EL
    Cancer Res; 1982 Nov; 42(11):4842-8. PubMed ID: 6181869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value of acid phosphatase and beta-glucuronidase activity in biopsy specimens from patients with reactivated prostatic cancer.
    Nilsson T; Müntzing J
    Scand J Urol Nephrol; 1975; 9(3):205-7. PubMed ID: 1209176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma.
    Festuccia C; Vincentini C; di Pasquale AB; Aceto G; Zazzeroni F; Miano L; Bologna M
    Oncol Res; 1995; 7(3-4):131-8. PubMed ID: 8555646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitive effect of soybean isoflavone on prostate hyperplasia in rats].
    Ren GF; Huang YM
    Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):343-6. PubMed ID: 14653113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer?
    Quinones GR; Rohner TJ; Drago JR; Demers LM
    J Urol; 1981 Mar; 125(3):361-4. PubMed ID: 6162969
    [No Abstract]   [Full Text] [Related]  

  • 31. Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.
    Wang Y; Hayward SW; Donjacour AA; Young P; Jacks T; Sage J; Dahiya R; Cardiff RD; Day ML; Cunha GR
    Cancer Res; 2000 Nov; 60(21):6008-17. PubMed ID: 11085521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma.
    Boag AH; Young ID
    Mod Pathol; 1993 Jan; 6(1):65-8. PubMed ID: 7678936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractionation and purification of prostatic acid phosphatase.
    Pais VM; Mangold AW; Mahoney SA
    Invest Urol; 1974 Jul; 12(1):13-6. PubMed ID: 4135033
    [No Abstract]   [Full Text] [Related]  

  • 35. [Histochemical characteristics of the prostate gland under normal conditions, in nodular hyperplasia and cancer].
    Bialik VV
    Arkh Patol; 1973; 35(12):12-8. PubMed ID: 4130950
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in type 1 collagen gels.
    Hall JA; Maitland NJ; Stower M; Lang SH
    Cancer Res; 2002 Jan; 62(1):58-62. PubMed ID: 11782359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
    Canal P; Soula G
    Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
    Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
    APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of prostatic acid phosphatase assays.
    Wise WS; Kandaswamy K
    Arch Pathol Lab Med; 1981 Nov; 105(11):622-5. PubMed ID: 6170271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.